Protara Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-8.2M | $-8.3M | $67.0K | $110.0K |
| FY2013 | $-6.7M | $-6.7M | $10.0K | $155.0K |
| FY2014 | $-10.0M | $-10.0M | $51.0K | $459.0K |
| FY2015 | $-17.6M | $-17.8M | $198.0K | $2.2M |
| FY2016 | $-23.7M | $-24.0M | $271.0K | $3.3M |
| FY2017 | $-22.4M | $-22.4M | $35.0K | $3.2M |
| FY2018 | $-23.2M | $-23.4M | $119.0K | $3.4M |
| FY2019 | $-5.0M | $-5.5M | $475.0K | $424.0K |
| FY2020 | $-23.4M | $-24.3M | $884.0K | $9.7M |
| FY2021 | $-34.5M | $-35.1M | $596.0K | $10.4M |
| FY2022 | $-26.5M | $-26.6M | $120.0K | $6.7M |
| FY2023 | $-37.6M | $-37.6M | $45.0K | $6.1M |
| FY2024 | $-35.8M | $-35.9M | $63.0K | $4.1M |
| FY2025 | $-56.4M | $-56.5M | $94.0K | $3.8M |